PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-307

  1. 4,354 Posts.
    lightbulb Created with Sketch. 6896
    Maybe a little but I wouldn't have thought it would've added that much buying pressure? There were 450 presenters at that conference in one format or the other? I guess it all helps! There is precedence of these such seminars being accretive to a share price.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.